CVS, JNJ, and Tenet Healthcare shine as defensive picks with strong earnings momentum and attractive valuations.

Zacks.com users have recently been watching Johnson & Johnson (JNJ) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Johnson & Johnson (NYSE: JNJ) is one of the top cheap pharmaceutical stocks to buy now. On July 29, Johnson & Johnson ...

PNC Financial Services Group Inc. trimmed its Johnson & Johnson holdings by 0.5%, now controlling around 6 million shares.

Detailed price information for Adobe Systems Inc (ADBE-Q) from The Globe and Mail including charting and trades.

Shockwave Medical CMO Dr. Nick West discusses the intravascular lithotripsy developer's plans for next-gen devices and new ...

Johnson & Johnson witnessed a notable increase in interest from Private Advisory Group LLC, which upped its holdings by 61.8% ...

XOMA Royalty Corporation is to buy fellow US firm LAVA Therapeutics for $1.16 to $1.24 per share in cash, plus a contingent value right (CVR), the companies announced Monday.

Why pharma companies' "price transparency" reports paint a murky picture of how much Americans spend on prescription drugs.

Submission is supported by 24-week results from the Phase 3b APEX study in adults with active psoriatic arthritis treated ...

Newly published research shows up to 77% of patients in Asia Pacific trust and rely on their physicians to decide their treatment for them despite 69% of physicians encouraging patients to engage in ...

AbbVie's Q2 results show Skyrizi and Rinvoq powering growth, offsetting Humira declines and lifting 2025 sales outlook.